![Michael Engsig](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Engsig
Algemeen Directeur bij
NYKODE THERAPEUTICS
Vermogen: 24 371 $ op 31-05-2026
Profiel
Michael Thyrring Engsig currently works at Nykode Therapeutics ASA, as Chief Executive Officer from 2019 and FluoGuide A, as Independent Director from 2023.
Mr. Engsig also formerly worked at Takeda A, as Director-Research & Development and KLIFO A, as EVP-Drug Development Counselling.
Mr. Engsig received his graduate degree from Technical University of Denmark.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 10-10-2025 | 71.794 ( 0,02% ) | 24 371 $ | 31-05-2026 |
Actieve functies van Michael Engsig
| Bedrijven | Functie | Begin |
|---|---|---|
| NYKODE THERAPEUTICS | Algemeen Directeur | 01-01-2019 |
| FLUOGUIDE A/S | Directeur/Bestuurslid | 01-01-2023 |
Eerdere bekende functies van Michael Engsig
| Bedrijven | Functie | Einde |
|---|---|---|
KLIFO A/S
 KLIFO A/S Miscellaneous Commercial ServicesCommercial Services Provides clinical research services | Corporate Officer/Principal | - |
Takeda A/S
 Takeda A/S Financial ConglomeratesFinance Engages in holding or owning securities of companies | Hoofd Techniek/Wetenschap/O&O | - |
Opleiding van Michael Engsig
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
5
Eerstegraads connecties
5
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
Technical University of Denmark
 Technical University of Denmark Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
KLIFO A/S
KLIFO A/S Miscellaneous Commercial ServicesCommercial Services Provides clinical research services | Commercial Services |
Takeda A/S
Takeda A/S Financial ConglomeratesFinance Engages in holding or owning securities of companies | Finance |
Nykode Therapeutics ASA
 Nykode Therapeutics ASA Pharmaceuticals: MajorHealth Technology Develops vaccines and immunotherapy against infectious diseases and cancer | Health Technology |
FluoGuide A/S
 FluoGuide A/S Pharmaceuticals: MajorHealth Technology Engages in the development of drugs used for the improvement of surgical outcomes by making cancer fluorescent | Health Technology |
